Menu
Recruiting NCT05270616

Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery

No phase Interventional Lung Diseases Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: robotic surgery, uniport surgery, multiple- port surgery.
Who it may be relevant to
Registry conditions: Lung Diseases, Surgery. Basic parameters: 18 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection. Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.

Interventions

  • Procedure robotic surgery
    minimally invasive surgery using the Davinci robotic system
  • Procedure uniport surgery
    VATS minimally invasive surgery under the uniportal status
  • Procedure multiple- port surgery
    VATS minimally invasive surgery under the multiple- port status

Primary outcome measures

  • mortality [Time frame: 30 days after surgery]
  • conversion rate to open surgery [Time frame: during surgery]
  • postoperative complications [Time frame: within 7 days after surgery]
  • operation time [Time frame: within 180 minutes]
  • duration of hospitalization [Time frame: within 7 days after surgery]
  • days to tube removal [Time frame: within 7 days after surgery]
  • retrieved lymph node [Time frame: within 1 days after surgery]
  • retrieved lymph node station [Time frame: within 1 days after surgery]
  • short- term PFS [Time frame: 3 years]
  • short- term overall survival [Time frame: 3 years]

Eligibility criteria

Inclusion criteria

  • good cardio- pulmonary function to tolerate surgery;
  • minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy;

Exclusion criteria

  • cardio- pulmonary function is not good enough to tolerate surgery;
  • huge tumor or extensive adhesion in thoracic cavity.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

China · 1 center
  • The Second Hospital of Shandong University — Jinan

Identifiers

NCT: NCT05270616 · Robotic lung ZYP

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗